Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapyNatasha B Leighl, Heather L Shepherd, Phyllis N Butow, et al.Cancer|October 16, 2013
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialJolie Ringash, Heather-Jane Au, Lillian L Siu, et al.Investigational New Drugs|May 7, 2013
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)Suzanne Richter, Philippe L Bedard, Eric Xueyu Chen, et al.The Lancet. Oncology|November 22, 2012
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Eric Van Cutsem, Hans-Joachim Schmoll, et al.Scientific Reports|January 19, 2020
Latency and interval therapy affect the evolution in metastatic colorectal cancerHamid Nikbakht, Selin Jessa, Mahadeo A Sukhai, et al.European Journal of Cancer (Oxford, England : 1990)|December 11, 2017
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinomaMaeve A Lowery, David P Kelsen, Marinela Capanu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 TrialLillian L Siu, Jeremy D Shapiro, Derek J Jonker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17Christos S Karapetis, Derek Jonker, Manijeh Daneshmand, et al.JCO Precision Oncology|February 9, 2022
Minimally Invasive Real-Time Detection of Actionable Mutations in Patients With Metastatic Solid Tumors Using Fine-Needle and Liquid BiopsiesKyaw L Aung, Philippe L Bedard, Celeste Yu, et al.Cancer|January 17, 2018
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinomaEileen M O'Reilly, Jonathan W Lee, Maeve A Lowery, et al.Pageof 10